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Summary
Mice with mutations in CD19 Y482/Y513 form germi-
nal centers (GC) but fail to produce high-affinity anti-
bodies. In these mice, GC B cell differentiation, prolif-
eration, and class switching occur but are defective.
Altered CD19 signaling results in retention of early
GC B cells and reduced proliferation in the follicular
dendritic cell (FDC) zone of GC, and causes failure to
select for high-affinity mutations. In normal mice, the
earliest detectable aggregates of GC B cells are in
contact with FDC and IgM+ cells are only found in the
FDC zone, further evidence that the FDC zone is the
site of initial GC B cell proliferation, differentiation,
and class switching. Proliferation in the non-FDC
zone and somatic mutation are not dependent on
CD19, indicating separate signaling requirements for
the two GC compartments, but these CD19-indepen-
dent GC functions are not sufficient to generate high-
affinity antibodies and B cell memory.
Introduction
The germinal center (GC) is the principal site of affinity
maturation and for generation of B cell memory (Gul-
branson-Judge et al., 1997; MacLennan, 1994; McHeyzer-
Williams, 2003). GC B cells proliferate rapidly and un-
dergo mutation and breakage of the chromosomal DNA
in the immunoglobulin (Ig) locus while under intensive
positive and negative selective pressure (Kelsoe, 1996;
Liu et al., 1997; McHeyzer-Williams, 2003). Our under-
standing of the signals that regulate these processes is
limited (Camacho et al., 1998; Haberman and Shlomchik,
2003; Manser, 2004).
CD19 is essential for normal antibody responses
(Fearon and Carrol, 2000). CD19 tyrosines 482 and 513,
the binding sites of the p85α unit of phosphatidylinosi-
tol-3 kinase (PI3K), are required for most physiological
functions of CD19 (Wang et al., 2002). CD19−/− mice
expressing transgenic CD19 with mutations in tyrosines
482 and 513 (CD19 Y482F/Y513F Tg) develop GC after
immunization with sheep red blood cells (SRBC) or nit-
rophenylacetyl-chicken gamma globulin (NP-CGG), but
fail to produce specific IgM or IgG1 antibody after pri-
mary immunization and have no recall response (Wang
et al., 2002). These observations suggest that CD19
signaling is essential at a crucial stage within the GC*Correspondence: rcarter@uab.eduresponse. The current study was undertaken to identify
the defect in GC in CD19 Y482F/Y513F Tg mice.
Antibody responses to T-dependent (TD) antigens are
first detected in the periarteriolar lymphoid sheath
(PALS) (Kelsoe, 2003). For bacterial antigens, the re-
sponse is initiated by marginal zone (MZ) B cells (Martin
and Kearney, 2002). MZ B cells move to the PALS,
where they serve as antigen-presenting cells for T cells,
then migrate through bridging channels into the red
pulp and differentiate into plasmablasts (Attanavanich
and Kearney, 2004; Song and Cerny, 2003). This pro-
vides a rapid first line of defense, but is not associated
with affinity maturation or memory.
GC appear 2–4 days after immunization. GC B cells
can be identified by binding of peanut agglutinin (PNA)
and by the fact that they are in cell cycle. The standard
model of GC development is based on the identification
by light microscopy of a dark zone, proximal to the
PALS, and a distal light zone, in GC of human tonsils
(Gulbranson-Judge et al., 1997; MacLennan, 1994;
McHeyzer-Williams, 2003). A widely accepted model
holds that (1) most B cells in the dark zone, called
centroblasts, are dividing while B cells in the light zone,
called centrocytes, are quiescent; (2) centroblasts are
the precursors of centrocytes. These conclusions ap-
pear in recent reviews (Haberman and Shlomchik, 2003;
Hollowood and Goodlad, 1998; McHeyzer-Williams,
2003) and textbooks.
These models are based largely on a study of changes
in localization of 5-bromo-2-deoxyuridine (BrdU)-labeled
B cells in GC in rats, which had previously been primed
with protein carrier before challenge with haptenated
carrier (Liu et al., 1991; MacLennan, 1994). The ready
availability of T cell help in these rats may have resulted
in a different response than a true primary GC. Analysis
of GC in mouse spleens has yielded partially different
results. A histological study of spleens from immunized
mice after a brief pulse of BrdU revealed labeled B cells
throughout GC, including within the follicular dendritic
cell (FDC) network, which is found in the light zone
(Rahman et al., 2003). Cells expressing Ki67, a marker
of cells in cell cycle, were also distributed throughout
GC (Kosco-Vilbois et al., 1997). However, an immuno-
histochemical study also suggested that the first aggre-
gates of cycling, PNA+ B cells, appear adjacent to, but
not in, the FDC network (Camacho et al., 1998). Over
time, these cells were thought to expand and enter the
FDC network, only later creating a two-compartment
system analogous to the dark and light zones of GC in
human tonsils. Thus, these studies in mice suggest that
B cells in both compartments are in cell cycle, but sup-
port the conventional model of progression of GC, with
initiation in the dark zone and then movement into the
light zone.
The signaling defect in CD19 Y482F/Y513F Tg mice
causes a delay in maturation of GC B cells, which re-
sults in an accumulation of B cells with an early GC
phenotype in the FDC zone of established GC. This ob-
servation, together with corroborating findings in nor-
mal mice, demonstrates that initial GC B cell differentia-
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750tion occurs in the FDC zone of GC in mouse spleens, n
wrather than the non-FDC zone as suggested by other
models. Furthermore, proliferation in the FDC zone, c
mclass switching, and selection are all abnormal in the
mice with defective CD19 signaling. Thus, B cell matu- m
cration, proliferation, class switching, and positive selec-
tion in the FDC zone require CD19 signals, and these w
tare regulated by different signals than the proliferation
of B cells in the non-FDC zone of GC. f
s
GResults
t
Impaired Differentiation in GC in CD19
Y482F/Y513F Tg Mice s
vCD19 Y482F/Y513F Tg mice formed GC after immuni-
zation with SRBC or NP-CGG but nevertheless pro- s
vduced almost no detectable antigen-specific serum an-
tibody (Wang et al., 2002). This observation suggests I
mthat CD19 regulates a critical step within the GC reac-
tion. Therefore, we tracked the dynamic changes in GC 1
cstructure and numbers of GC B cells in CD19 Y482F/
Y513F Tg mice. The time course of GC B cell develop- 2
oment in CD19 Y482F/Y513F Tg mice was similar to that
of CD19+/+ mice, although the percentage of GC B cells c
cwas consistently lower in mice with mutant CD19 (Fig-
ure 1B). GC were present in spleen sections from immu- nFigure 1. GC Development Is Reduced in
CD19 Y482F/Y513F Tg Mice
CD19+/+ and CD19 Y482F/Y513F Tg mice
were immunized with SRBC and spleens
were analyzed at day 14 (A) or as indicated
(B and C). (A) The analysis of the percentage
of GC (Fashigh, PNA+) B cells, gated for lym-
phocytes and B220+ cells, is illustrated. (B)
The percentages of GC B cells among total
B220+ lymphocytes were evaluated as in (A).
The results are presented as the mean ± SD
from groups of at least three mice at each
time point. (C) Spleen tissue sections were
stained with PNA (green) and anti-IgM (red).
GC were induced in the spleens of CD19
Y482F/Y513F Tg mice over a time course
similar to that in wild-type mice, but were
smaller in mice with mutant CD19. The scale
bar represents 80 M.ized CD19 Y482F/Y513F Tg mice starting at day 4 but
ere smaller than in normal mice (Figure 1C). CD4+
ells and FDC-associated IgM and complement frag-
ents were equally present in CD19 normal and CD19
utant GC (data not shown). Thus, the overall time
ourse of GC formation and persistence was similar in
ild-type and CD19 Y482F/Y513F Tg mice, unlike GC
hat form and then collapse when T cell help is de-
ective (de Vinuesa et al., 2000). Mutation of CD19 tyro-
ines 482 and 513 results in a reduction in the size of
C, but has no apparent effect on the general struc-
ures of GC.
The transition from IgM+IgD+ to IgM+IgD− cells repre-
ents the initial differentiation step during early GC de-
elopment (Figure 2A) (Shinall et al., 2000), but the
ignals controlling this transition are unknown. We pre-
iously reported that significantly more GC B cells were
gD+ in CD19 Y482F/Y513F Tg mice, compared to nor-
al controls (Wang et al., 2002). In normal mice at day
0 after immunization, 90% of nonswitched, IgM+ GC
ells had downregulated the expression of IgD (Figure
B). In contrast, in CD19 Y482F/Y513F Tg mice, 77%
f IgM+ GC B cells remained IgD+ (Figure 2B). These
ells were PNA+, Fashigh and displayed phenotypic
haracteristics of early GC B cells. There were also sig-
ificantly more CD38+CD23+IgM+ cells in GC from
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751Figure 2. IgD+ Cells Are Retained in Splenic
GC from CD19 Y482F/Y513F Tg Mice
(A) Schematic view of B cell differentiation
during GC development.
(B) Spleens from mice immunized 10 days
previously were examined by flow cytometry.
B220+FashighIgM+ mononuclear cells were
further analyzed for expression of IgD. The
percentage of IgD+ cells within IgM+ GC cells
was calculated and shown.
(C and D) CD19+/+ (C) and CD19 Y482F/Y513F
Tg (D) mice were immunized with SRBC for 10
days. Tissue sections from spleen were
stained with PNA (green), anti-IgD (red), and
anti-CD35 (blue). Few IgD+ cells were identi-
fiable in GC from CD19+/+ mice (C), but IgD+
cells were readily detectable in the FDC zone
of GC in the spleens of CD19 Y482F/Y513F
Tg mice (D). The scale bar represents 40 m.CD19 Y482F/Y513F Tg mice (data not shown). To deter-
mine where CD19-dependent maturation occurred in
GC, we examined GC from wild-type and CD19 Y482F/
Y513F Tg mice histologically. Few IgD+ cells could be
observed within GC in normal mice (Figure 2C), consis-
tent with the flow cytometry results. In contrast, IgD+
cells were relatively abundant in GC from CD19 mutant
mice, but were present only in the FDC zone (Figure
2D). Thus, CD19 signaling regulates a major differentia-
tion step during GC maturation. Blocking this step re-
sults in an accumulation of early GC B cells in the FDC
zone of GC. This suggests that initial differentiation of
mouse splenic GC B cells after SRBC immunization oc-
curs in the FDC zone.
Location of IgM+ and Switched B Cells Inside GC
One possible explanation for the presence of B cells
with an early GC phenotype in the FDC zone in CD19
Y482F/Y513F Tg mice is that this is due to aberrant
homing as result of the mutation in CD19. As above,
IgD+ cells were rare in the normal GC, but IgM+ cells
were plentiful, and these IgM+ cells represent an earlierstage in the GC reaction than switched B cells. We
compared the localization of IgM+ and switched cells
(predominantly IgG1). Virtually all mouse GC B cells
(B220+PNA+) express BCR, as detected by staining for
surface light chains, although some express surface
BCR at a lower level than non-GC B cells (B220+PNA−)
(data not shown). At day 10 after immunization of wild-
type mice with SRBC, IgM+ cells represented about
36% of GC B cells (data not shown). In spleen sections
from these mice, IgM was detected only in the CD35+
FDC zone (Figure 3A). When examined carefully, IgM
signals in the FDC zone appeared as both membrane
IgM on B cells and soluble IgM captured by FDC. In
contrast to IgM, IgG1 was also present in the non-FDC
zone, where the signal appeared as membrane bound
IgG1 on GC B cells (Figure 3A). Therefore, IgM+ GC B
cells are in the FDC zone, while switched cells are in
both the FDC zone and the non-FDC zone. Almost all
IgG1+ cells in the non-FDC zone stained positive for
anti-Bcl6 staining (data not shown), indicating they are
GC B cells and not plasma cells. Thus, Ig class switch-
ing is initiated and completed in the FDC zone. Early-
Immunity
752Figure 3. Localization of GC B Cells Correlates with Development Stages
(A) Spleens from CD19 normal mice immunized 10 days previously with SRBC were analyzed by immunofluorescent microscopy after staining
with the indicated antibodies or PNA. IgM staining was detectable in the FDC zone but was absent in the non-FDC zone. In contrast, both
the FDC and the non-FDC zone stained for IgG1.
(B–D) Tissue sections of spleens from normal mice immunized 2 (B), 3 (C), and 4 (D) days previously with SRBC were stained with PNA
(green), anti-CD35 (blue), and anti-IgD (magenta). The initial clusters of PNA+ cells were colocalized with the CD35+ FDC network and then
expanded to form both FDC and non-FDC zones.
(E) A GC at day 10 was stained with PNA (green), anti-CD35 (blue), anti-IgD (red), and anti-CD4 (magenta). The non-FDC zone of this GC had
extended to the T-B boundary. CD4+ cells were predominantly in the FDC zone of GC.
The scale bar represents 40 M in (A), (B), (D), and (E) and 80 M in (C). CA: central arteriole.
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in the non-FDC zone in normal mice, suggesting that
the accumulation of IgD+ cells in the FDC zone in CD19
Y482F/Y513F Tg mice is not the result of faulty local-
ization.
Development of Murine Splenic GC
The above experiments examined established GC. Per-
haps, with an antigen such as SRBC, additional B cells
with an early GC phenotype are recruited into the FDC
zone of GC over time, but the B cells that initially form
GC are not in contact with FDC, consistent with previ-
ous publications (Camacho et al., 1998). Therefore, we
studied the initiation of GC in follicles. Aggregates of
PNA+ GC B cells first appeared inside follicles 2 days
after immunization with SRBC. In normal mice, the ear-
liest detectable clusters of PNA+ cells in follicles were
in close contact with FDC (Figures 3B and 3C). Further-
more, the PNA+ cells and the FDC were in the middle
of the follicular mantle, well separated from the T-B
boundary. Similar results were also observed with hen
egg lysozyme immunization, demonstrating that the
observation is not limited to GC induced by SRBC (Fig-
ure S1). Thus, GC form as aggregates of PNA+ cells in
the region of the FDC zone closest to the PALS, but
clearly in contact with the FDC network. Most PNA+
cells at this stage have already downregulated the ex-
pression of IgD, indicating the rapid development of
cells with a mature GC phenotype. By day 4, the aggre-
gates of PNA+ B cells expanded both deeper in the FDC
zone (towards the marginal sinuses) and also away
from the FDC towards the PALS, to form two compart-
ments: a FDC zone and a non-FDC zone of the GC (Fig-
ure 3D). Therefore, in mice, GC form when precursor B
cells make contact with FDC and then rapidly develop
and maintain a FDC zone and a non-FDC zone. Initial
differentiation of GC B cells (days 2–4), like that in
established GC (day 10, Figure 3E), occurs in proximity
to FDC.
Mutations on CD19 Y482/Y513 Suppress
Proliferation of IgM+ Cells within the FDC Zone
To determine why GC are smaller in CD19 Y482F/Y513F
Tg mice than in wild-type, we analyzed cell cycling in
the two sets of mice. By immunofluorescence micros-
copy, B cells in both the FDC and non-FDC zones were
positive for expression of Ki67 (Figure 4A). These mice
had been exposed to BrdU for 1.5 hr before sacrifice,
and BrdU incorporation was analyzed on contiguous
sections from these same spleens. Cells that had incor-
porated BrdU were apparent in both the FDC and non-
FDC zones, with equivalent staining intensity (Figure
4B). Most of the cells in the FDC zone are Ki67+ (Figure
S2). Similar localization of Ki67+ cells in the FDC zone
of GC persisted at least until day 17 (Figure S3). In addi-
tion, what appear to be mitotic figures could be iden-
tified closer to the outer edge of GC, away from the
PALS, on H&E stains for paraffin-embedded sections
(Figure S4). Thus, although previous studies with BrdU
labeling and analysis of Ki67+ cells have given contra-
dictory results (Kosco-Vilbois et al., 1997; Liu et al.,
1991, 1996a; MacLennan, 1994; Rahman et al., 2003),
proliferating cells were clearly distributed in both theFDC and the non-FDC zones in the mouse splenic GC.
That cells in the FDC zone are in cycle is consistent
with our previous observation that IgM+ GC B cells,
which we now know to be located only in the FDC zone,
are in cell cycle in normal mice (Wang et al., 2002).
Thus, the FDC and non-FDC GC zones in mice are ana-
tomically analogous to the light and dark zones of hu-
man tonsils, but both zones support proliferation in mu-
rine splenic GC.
BrdU+ GC B cells were apparent in spleen sections
from CD19 Y482F/Y513F Tg mice at day 10 after immu-
nization, but most were located within the non-FDC
zone, close to the T-B boundary (Figure 5). Even after a
6 hr pulse, few BrdU+ cells could be identified in the
FDC zone from CD19 Y482F/Y513F Tg GC (note the
empty nuclei surrounded by PNA+ cytoplasm in the FDC
zone). Similar results were observed for at least ten GC
each from three mice at days 7, 10, and 14 after
SRBC immunization.
As IgM+ GC B cells are located inside the FDC zone
and proliferation of B cells in the FDC zone is de-
creased in CD19 Y482F/Y513F Tg mice, we measured
BrdU incorporation by splenic IgM+ and IgM− GC B
cells. In mice with defective CD19, the average percent-
ages of all GC B cells entering S phase were decreased
to 14% and 32% after 3 and 6 hr BrdU labeling, respec-
tively, compared to 20% and 40% in normal mice (re-
presentative data shown in Figure 6A and mean values
in Figure 6B). However, the decrease was more pro-
found in the IgM+ GC B cell subset. With 3 and 6 hr
labeling, mean percentages of IgM+BrdU+ cells among
total GC B cells were 1.1% and 2.3%, respectively, in
CD19 mutant mice compared to 5.6% and 14% in nor-
mal mice, a 5- to 6-fold difference. Considering that the
total number of GC B cells in normal mice was 2- to
3-fold greater than in CD19 Y482F/Y513F Tg mice (Fig-
ure 1B), the absolute number of proliferating GC IgM+
cells was reduced by at least an order of magnitude in
the CD19 mutant mice. Similarly, the percentage of
cells expressing Ki67 was more reduced in the IgM+
population than in switched cells in GC from mice with
mutant CD19: on average, 31% of IgM+ GC cells were
Ki67+ in CD19 mutant mice, compared to 80% in nor-
mal mice (representative data shown in Figure 6C and
mean values in Figure 6D). Among total GC B cells, an
average of only 5.1% were IgM+Ki67+ in CD19 mutant
mice, compared to 32% in CD19 normal mice.
Altered Selection in CD19 Y482/Y513 Tg Mice
To determine whether the defects observed in the FDC
zone of GC in mice with mutant CD19 altered selection,
we analyzed Ig sequences for evidence of generation
of high-affinity B cell clones. Immunization of 129/Sv
mice with the antigen 2-phenyloxazolone (phOx) cou-
pled to chicken serum albumin (CSA) induces a well-
characterized, restricted immune response (Berek and
Milstein, 1988). The majority of phOx-specific antibod-
ies have one particular heavy and light chain combina-
tion, referred to as VhOx1 and VκOx1 (or κκ4 [Schable
et al., 1999]), containing VκOx1, a member of the Vκ4/5
gene family, rearranged to Jκ5. PhOx-specific antibod-
ies from the early stages (day 7) of a response have low
affinity and few somatic mutations and are promiscu-
Immunity
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(A–C) Serial section of spleens from CD19 normal mice, immunized 10 days previously with SRBC and injected with BrdU 1.5 hr before
sacrifice, were analyzed by immunofluorescence microscopy. (A) The section was stained with PNA (green), anti-Ki67 (red), and anti-CD35
(blue). Red, Ki67+ cycling cells were distributed evenly in the FDC zone and the non-FDC zone. (B) An adjacent section was stained with PNA
and anti-BrdU (red). To show the localization of cells with incorporated BrdU, the image of CD35 staining was merged with image of BrdU
from the same GC on the adjacent section. Red: BrdU+ cells were found in the FDC and non-FDC zones. (C) The anti-BrdU signal was
localized within PNA+ B cells, consistent with nuclear localization. The scale bar represents 40 M in (A) and (B) and 20 M in (C).ous in using multiple, closely related Vκ genes from the r
tVκ4/5 family (Kaartinen et al., 1983). By day 14, anti-
body sequences show a more restricted repertoire and b
mdisplay mutations that lead to an increased affinity (Be-
rek et al., 1991). CD19+/+ or CD19 Y482F/Y513F Tg mice
iwere immunized with phOx-CSA in alum. Fourteen days
after immunization, genomic DNA was prepared from m
ssorted B220+PNA+ cells. The primers used for PCR
were chosen so as to examine the usage of all mem- r
abers of the Vκ4/5 gene family that have rearranged to
Jκ5. Most sequences of the Vκ4/5 family isolated from t
mGC cells from CD19 normal and mutant mice were mu-
tated, with overall frequency of mutations of 3.05 and T
z1.66 mutations per sequence (9 and 4.9 bases per kilo-
base), respectively (Figure 7A). The frequency of muta- p
itions in mice with defective CD19 signaling was ap-
proximately 2-fold lower than in the normal mice that 1eceived the same immunization, but was higher than
he rate of Taq polymerase errors (0.1 mutation per kilo-
ase). Thus, CD19 signaling is not required for somatic
utation in GC.
Analysis of the repertoire composition of GC B cells
n CD19 normal and mutant mice after phOx-CSA im-
unization revealed a major role of CD19 signaling in
election. In wild-type animals, there was a significant
estriction in repertoire toward usage of VκOx1 (36% of
ll Vκ4/5 genes) (Figure 7B), and the restricted reper-
oire had accumulated a higher frequency of somatic
utations, consistent with previous reports (Figure 7C).
he hallmark of affinity maturation after phOX immuni-
ation is the mutation of histidine at position 31 to as-
aragine or glutamine, which increases antibody affin-
ty by 10- or 8-fold, respectively (Berek and Milstein,
987). This type of mutation was present in 13 out of
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755Figure 5. CD19 Y482F/Y513F Tg Mice Have
Reduced Proliferation in the FDC Zone
CD19+/+ (A and C) or CD19 Y482F/Y513F Tg
(B and D) mice, which had been immunized
with SRBC 10 days previously, were injected
with BrdU for 3 (A and B) or 6 hr (C and D)
before sacrifice. Adjacent sections of spleens
were stained with PNA (green) and anti-BrdU
(red) or with PNA (green) and anti-CD35
(blue). Using images of PNA staining as a
guide, images of anti-BrdU staining were
merged with images of CD35 staining on the
adjacent sections of the same GC to deter-
mine the localization of BrdU+ cells relative
to CD35+ FDC. Consistently, few BrdU+ cells
were found in the FDC zone in GC from
CD19 Y482F/Y513F Tg mice. The scale bar
represents 40 M.21 sequences analyzed from CD19 normal mice. In
contrast, the percentage of VκOx1 gene among Vκ4/5
family was reduced to 17% in GC B cells from CD19
mutant mice (Figure 7C). Furthermore, none of the se-
quences isolated from GC of mice with defective CD19
contained the mutations that are characteristic of in-
creased affinity (Figure 7C). Also striking was the differ-
ence in amino acid usage on position 96 in the CDR3,
which is an important contact residue in the binding
site of phOx-specific antibodies (Berek et al., 1991). In
germline sequences of non-GC B cells of normal mice,
80% use leucine at position 96 and 20% used proline
due to the imprecise rearrangement of VκJκ5 gene. In
contrast, almost all GC B cells from normal mice use
leucine at position 96, indicating that there is strong
preference for leucine at this position and sequences
with proline 96 are excluded (Berek et al., 1991). Con-
sistent with previous reports, after 14 days of phOx-
CSA immunization, in normal mice 95% of GC se-quences encoded leucine at position 96 (Figure 7C).
However, 3 out of 11 sequences from CD19 mutant
mice used proline in place of leucine, again suggesting
impaired selection. It is unlikely that CD19 mutant mice
would use noncanonical Vκ to generate high-affinity
anti-phOx antibodies, because (1) the VκOx1 gene still
out-numbered other Vκ4/5 family members in CD19
mutant GC, and (2) none of the sequences from CD19
mutants displayed the mutations that are known to in-
crease affinity. Thus, antigen-driven clonal selection in
GC is diminished by the mutations in CD19.
To determine whether the diminished CD19 signal
would affect Ig class switching, the percentages of
cells expressing IgM, IgG1, and IgG2 (a and b) were
measured by flow cytometric analysis after SRBC im-
munization. On days 4 and 7 after immunization of nor-
mal mice, the percentages of total GC B cells that were
IgM+ were 75% and 50% on average, respectively (Fig-
ure 7D and data not shown). In contrast, the percent-
Immunity
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(A–D) Spleen mononuclear cells, isolated from mice that were immunized 10 days previously and exposed to BrdU either 3 or 6 hr before
sacrifice, were analyzed by flow cytometry. (A) B220+Fashigh GC B cells were analyzed for the expression of IgM and incorporation of BrdU.
(B) Percentages of BrdU+, IgM+BrdU+, and IgM−BrdU+ in the B220+Fashigh GC B cell population were calculated from flow cytometric analysis
as in (A). The bars represent the mean percentage ± SD from each group. (C) B220+Fashigh GC B cells were analyzed for the expression of
IgM and Ki67. More than 80% IgM+ GC cells in CD19 normal mice were Ki67+, compared to ~27%–35% in CD19 Y482F/Y513F Tg mice. (D)
Mean percentages ± SD of Ki67+ cells in IgM+ and IgM− GC B cell population were calculated from flow cytometric analysis. (A and C) The
numbers shown are the percentages of cells in the different quadrants. (B and D) Comparisons between CD19+/+ and CD19 Y482F/Y513F Tg
mice with statistically significant differences are shown (%, p < 0.05). (A–D) All groups included at least three mice, and all individual plots
are representative.ages of total GC B cells that were IgM+ cells in CD19 s
mY482F/Y513F Tg mice at days 4, 7, and 14 were 30%,
20%, and 15%, respectively, under identical immuniza- a
ttion conditions (Figure 7D and data not shown), consis-
tent with the observation that the proliferation of IgM+ f
cells was reduced in CD19 mutant mice. In normal mice
at day 14, the majority of GC B cells expressed IgG1, D
accounting for 60% of total GC B cells. In CD19 Y482F/
Y513F Tg mice at day 14 after SRBC immunization, M
fswitching was predominantly to IgG2a and IgG2b (54%,
compared to 8.9% in CD19 normal mice) (Figure 7D),imilar to what we previously reported in NP-CGG im-
unized mice (Wang et al., 2002). Thus, CD19 signals
re not required for class switching, but they are impor-
ant for determining subclass-specific switching and/or
or expansion of selected, switched GC B cells.
iscussion
ice with mutations in the PI3K binding site in CD19
orm GC but fail to produce specific antibodies afterprimary immunization or a memory response after
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757Figure 7. CD19 Y482 and Y513 Are Required
for Positive Selection of GC B Cells
(A–C) Sequences of Vκ4/5 family light chains
rearranged to Jκ5 from GC B cells that were
isolated from mice immunized with phOx-
CSA 14 days previously were analyzed. Re-
sults are generated from eight pooled mice.
(A) Distribution of mutation in GC B cells.
The area of each sector in the pie charts rep-
resents the proportion of clones with the in-
dicated number of mutations; the total num-
ber of clones analyzed is indicated in the
central circle of each pie; the average num-
ber of mutation per sequence is shown on
top of the charts. (B) Frequencies of Vκ4/5
family usage were determined by the pro-
gram DNAplot and are shown. (C) Se-
quences of VκOX1(κκ4) rearranged to Jκ5
were analyzed, and the variances in amino
acid usage at positions 31 and 96 were com-
pared between CD19 and CD19 mutant. Mu-
tation on His31 to Asn or Gln will increase
antibody affinity by 10- or 8-fold, respec-
tively. Almost all high-affinity antibodies use
Leu at position 96. GC B cells using Pro at
position 96 were identified only in CD19 mu-
tant mice. The numbering is according to
Kaartinen et al. (1983).
(D) The percentages of cells expressing IgM,
IgG1, and IgG2a/IgG2b among total GC B
cells were calculated after intracellular stain-
ing at days 7 and 14 post immunization. Val-
ues are expressed as mean percentage ±
SD. CD19 Y482F/Y513F Tg mice had signifi-
cantly higher percentages of GC B cells
expressing IgG2a and IgG2b and fewer ex-
pressing IgM and IgG1. Comparisons be-
tween CD19+/+ and CD19 Y482F/Y513F Tg
mice with statistically significant differences
are shown (%, p < 0.05). All groups included
at least three mice, and all individual plots
are representative.boosting with TD antigen (Wang et al., 2002). Thus,
these mice provide a model by which to understand the
signals that regulate GC B cell responses. The accumu-
lation of B cells at an early differentiation stage in the
GC response in the FDC zone not only indicates a
requirement for a specific signal transduction pathway
in the differentiation of GC B cells, but also suggests
that the FDC zone is the site of this early differentiation
step in the mouse spleen. The observations that IgM+
cells are only found in the FDC zone and, in normal
mice, are in cell cycle imply that multiple stages of B
cell differentiation occur in the FDC zone, including the
transition from IgM+IgD+ early stage to IgM+IgD−, ma-
ture, proliferative GC B cells and Ig class switching.
Therefore, GC B cells in contact with the FDC network
include a major subset that undergoes initial clonal ex-
pansion, differentiation, class switching, and selection.
Our observations in GC at days 2–4 after immuniza-
tion support the notion that FDC play an important role
for GC initiation by creating a nucleation site in the B
cell follicle. In contrast to previous interpretations, the
earliest detectable clusters of PNA+ cells were interdigi-
tated in the FDC network. These PNA+ cells were Ki67+
(Figure S1), and therefore in cell cycle, and had down-
regulated IgD expression, characteristics of mature GC
B cells. Differences from previous reports may relate tothe use of the 129/Sv mouse strain. However, the higher
resolution afforded by fluorescence microscopy per-
mits finer localization. GC are either absent or dis-
persed inside the PALS and are functionally abnormal
in mice without functional FDC in splenic follicles (Fu
and Chaplin, 1999; Voigt et al., 2000). FDC zones pro-
duce the chemokine CXCL13, which attracts B cells
that express CXCR5 (Breitfeld et al., 2000; Cyster et al.,
2000), providing an explanation for how motile B cells
come in contact with stationary FDC. Additionally, FDC
express high levels of ICAM-1 and VCAM-1, which bind
LFA-1 and VLA-4 on B and T cells, respectively (Balogh
et al., 2002; Koopman et al., 1994). This interaction
brings B and T cells into close physical contact with
FDC. These results suggest that forming GC in follicles
is highly dependent on FDC.
Thus, both the initiation of GC and the differentiation
of IgM+ cells at later stages occur in contact with the
FDC network. Interestingly, the initiation consistently
occurs on the side of the FDC zone closest to the PALS,
in agreement with earlier observations (Camacho et al.,
1998). However, the FDC are also in contact with IgD+
cells on the marginal zone aspect of the GC (Figures 2
and 4). PNA+IgD+ cells are difficult to detect in normal
mice but are apparent in CD19 Y482F/Y513F Tg mice,
presumably due to a delay in their differentiation. At day
Immunity
75814, these cells are unlikely to represent progeny of the i
Ginitial GC founder cells because they are not in cell cy-
cle. Thus, the mechanisms for initiation of GC (GC B m
mcells on the PALS-proximal aspect of FDC) and for re-
cruitment and maturation of additional B cells into GC z
s(GC B cells on the marginal zone aspect of FDC) may
differ. i
nThe selective impairment in CD19 mutant mice de-
monstrates that CD19 regulates GC development in a f
pstage-specific manner. CD19 Y482F/Y513F Tg mice
were able to initiate a GC reaction. The numbers of B p
icells with an early GC phenotype (PNA+, IgM+, IgD+,
CD38+) induced by immunization were similar to those a
tin normal mice (Wang et al., 2002). Thus, the initial acti-
vation to the PNA+ stage can be mediated by CD19- s
cindependent signaling. However, mice with mutations
in CD19 Y482 and Y513 demonstrated profound de- b
zfects in proliferation and differentiation of GC B cells
once recruited into the FDC zone. These mutations dis- e
arupt the interaction of CD19 with PI3K, which is essen-
tial for most CD19 function in vivo (Wang et al., 2002). 2
CInactivation of PTEN, an attenuator of PI3K signaling,
rescued GC formation in CD19−/− mice (Anzelon et al., G
b2003). The requirement for the CD19-PI3K association
is consistent with the role of PI3K in enhancing murine t
FB cell proliferation (Donahue and Fruman, 2003; Piatelli
et al., 2004). The defect in proliferation may result in o
othe reduced differentiation from the IgD+ to IgD− stage,
because cell cycling is linked to maturation programs t
oin GC B cells (Papavasiliou and Schatz, 2000; Petersen
et al., 2001). The histologic data suggest that the prolif-
beration of switched cells in the FDC zone is also re-
duced as well as that of IgM+ cells, which comprise a a
dminority of FDC zone B cells in mice with mutant CD19.
CD19 associates with CD21 on B cells (Fearon and e
WCarter, 1995). The natural ligand for CD21 is the com-
plement cleavage fragment C3dg. Mice deficient in w
ueither CD19 or CD21/CD35 or in components of the
classical complement pathway, C1q, C3, and C4, have p
Tdefects in the GC response, suggesting that comple-
ment activation, immune complex deposition on FDC, c
Gand CD19 signaling reside on the same linear pathway
in GC development (Fearon and Carrol, 2000). The d
zmodel is supported by our findings that CD19 mutant
GC B cells showed impairment in the FDC zone, where a
contact with complement-containing immune com-
plexes on FDC would occur. However, the defects in TD o
rantibody responses observed in CD21-deficient mice
could be rescued when antigens were administered e
twith adjuvant, but the defects seen in CD19 mutant
mice were not (Chen et al., 2000; Wang et al., 2002; Wu w
zet al., 2000), suggesting a CD21-independent function
for CD19. IgM and stromal cell-associated heparan sul- n
mfate or heparin have been identified as additional li-
gands for CD19, and both would be present on the sur- o
oface of FDC (de Fougerolles et al., 2001). Other reports
indicate that CD19 may enhance signaling by CD40 v
s(Gardby et al., 2001) and, in activated B cells, by MHC
class II (Bobbitt and Justement, 2000). Therefore, there c
pare multiple signaling pathways triggered by immune
complexes, FDC, and T cells in the FDC zone that could s
tutilize CD19.
In contrast to the defects observed in the FDC zone, a
wmutation of CD19 Y482 and Y513 showed no obviousnfluence on B cell proliferation in the non-FDC zone of
C. The cells in the non-FDC zone in the mice with
utant CD19 were Ki67+ and incorporated BrdU nor-
ally. Thus, proliferation in the FDC and non-FDC
ones requires different signals. A substantial literature
upports the concept that CD19 augments BCR signal-
ng. Therefore, we speculate that proliferation in the
on-FDC zone, once initiated, requires minimal signals
rom the BCR and thus provides a mechanism for ex-
ansion that is not dependent on affinity for antigen,
resumably driven by other mitogenic signals. In some
mages of the non-FDC zone of GC of day 7–14, taken
fter a brief exposure to BrdU, labeled cells appear at
he edge of the non-FDC zone adjacent to the PALS,
uggesting that the non-FDC zone GC B cells may re-
eive proliferative signals from the T cells at the T-B
oundary, distinct from GC T cells, which are in the FDC
one. Perhaps such proliferation may play a role in the
xpansion of GC observed in the absence of soluble Ig
nd detectable immune complexes (Hannum et al.,
000; Rossbacher and Shlomchik, 2003). Despite the
D19-autonomous proliferation in the non-FDC zone,
C in CD19 mutant mice failed to produce specific anti-
ody or B cell memory, and class switching was al-
ered. Therefore, it appears that proliferation in the non-
DC zone is insufficient, in itself, to lead to production
f specific antibody or memory B cells, either because
f decreased entry into this pool when proliferation in
he FDC zone is defective, or due to proliferation with-
ut positive selection.
Affinity maturation in GC selects high-affinity anti-
odies that contain particular mutations and are clon-
lly related. GC B cells without CD19 signaling had re-
uced proliferation and affinity maturation, and these
vents may be functionally linked inside the FDC zone.
ithout CD19 signaling, GC B cells in the FDC zone
ere less likely to enter the cell cycle, and probably
nderwent fewer rounds of somatic mutation, making
ositive selection based on BCR affinity more difficult.
hus, there were fewer overall amino acid sequence
hanges, and the repertoire was more promiscuous in
C B cells from CD19 mutant mice. However, our data
o not preclude recruitment of cells from the non-FDC
one back into the FDC zone, a process which could
lso be disrupted when CD19 signaling is defective.
In our assessment of GC, several observations, to
ur knowledge, are either novel or differ from previous
eports: PNA+ B cells are in contact with CD35+ FDC in
arly GC; IgD+PNA+ B cells enter into the FDC zone of
he GC; IgM+ GC B cells are only found in the FDC zone,
hile IgG+ cells are in both the FDC and the non-FDC
ones; GC B cells proliferate in both the FDC and the
on-FDC zones, but proliferation in the two compart-
ents is regulated by independent mechanisms. These
bservations suggest an alternate model of GC devel-
pment, at least in mice: GC are initiated when acti-
ated B cells make contact with the PALS-proximal
ide of the FDC network in the follicular mantle. GC B
ells proliferate and form two zones, which both ex-
and. The FDC form an arc that, in the mature GC,
tretches from just inside the marginal sinuses down to
he middle of the GC. IgM+ cells, potentially including
dditional cells recruited into GC by contact of the FDC
ith follicular B cells, proliferate in the FDC zone for
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759weeks. Affinity maturation occurs in the cells in the FDC
zone. Some cells in the FDC zone switch to IgG expres-
sion. Switching per se does not require CD19 signals,
but CD19 regulates the distribution of isotypes in sur-
viving cells. The switched cells either remain in the FDC
zone or move to the non-FDC pole of GC. Proliferation
continues in both zones, but through different signaling
mechanisms. The proliferation in the FDC zone requires
CD19 signals, induced by immune complexes and
other FDC-derived ligands, while that in the non-FDC
zone is CD19 independent, consistent with the expan-
sion of cells in this zone that, once activated, is largely
independent of B cell receptor affinity for antigen. Pro-
liferation in the non-FDC zone leads to mutations in Ig
genes, but these mutations and the proliferation in the
non-FDC zone are, in themselves, insufficient to give
rise to a detectable specific antibody response.
GC physiology may differ between species and be-
tween different lymphoid organs. For example, in hu-
man tonsils, IgM and IgG transcripts can both be
detected in human tonsil GC centroblasts and centro-
cytes by PCR, and centroblasts include cells with un-
mutated Ig genes (Pascual et al., 1994). In addition, rat
spleens and human tonsils have more striking differen-
tiation of light and dark zones by histology than mouse
spleens, and GC compartmentalization differs between
human lymph nodes and tonsils (Brachtel et al., 1996;
Hardie et al., 1993; Liu et al., 1991). However, the model
we have suggested here is supported by previous ob-
servations that murine GC B cells in both subregions
are proliferating (Camacho et al., 1998; Rahman et al.,
2003), that IgM+ cells are present persistently in mouse
GC (Shinall et al., 2000), and that Ig class switching oc-
curs in the FDC zone (Liu et al., 1996b). Our observa-
tions in mice with mutant CD19 emphasize that events
in the FDC zone (proliferation, maturation, class switch-
ing, and positive selection) are essential for the pro-
duction of specific antibody and B cell memory.
Experimental Procedures
Mice and Immunization
Generation and maintenance of CD19 Y482F/Y513F Tg mice have
been described previously (Wang et al., 2002). All mice, on the 129/
Sv background, were maintained in accordance with institutional
policies for animal care and use. Eight- to twelve-week-old CD19+/+
and CD19 Y482F/Y513F Tg mice were immunized with 0.1 ml of
SRBC (Colorado Serum, as withdrawn directly from bottle) by in-
traperitoneal injection. PhOx was conjugated with CSA at a ration
of 10 to 1, as described (Berek, 2004). Mice were immunized with
0.1 mg of alum precipitated phOx-CSA or hen egg lysozyme by
intraperitoneal injection. For BrdU in vivo labeling experiments, im-
munized mice received BrdU (Sigma) as a 1 mg intraperitoneal in-
jection in sterile PBS.
Flow Cytometric Analysis
Splenocytes were stained as described previously (Wang et al.,
2002) with combinations of FITC-labeled PNA (Vector Laboratory),
PE conjugated anti-Fas (Jo2), PerCP anti-B220 (RA3-6B2), biotin-
ylated anti-mouse IgG1 (A85-1), FITC anti-BrdU (3D4), anti-Ki67
(B56), anti-IgG2a (R19-15), anti-IgG2b (R12-3) (BD Biosciences,
San Diego, CA), FITC anti-IgD (11-26), biotinylated anti-κ (187.1)
and anti-λ (JC5-1) (Southern Biotech Associates), and biotinylated
F (ab) goat anti-IgM ( chain specific) (Jackson Immunoresearch
Laboratories). Biotin conjugates were visualized with streptavidin-
allophycocyanin (SA-APC, BD Biosciences). Flow cytometry wasperformed on a FACSCalibur (BD Biosciences) and analyzed with
WINMDI version 2.8.
For BrdU and Ki67 staining, five million splenocytes were sur-
face-stained with PE anti-Fas, fixed and permeabilized with Cyto-
perm/Cytofix buffer (BD Biosciences) for 30 minutes on ice, followed
by secondary fixation/permeabilization solution of 0.5%Tween/1%
paraformadyhyde in PBS for 30 minutes at room temperature. To
expose the targets for anti-BrdU, genomic DNA was digested at
37°C with 30 g deoxyribonuclease I (Sigma) in 100 l PBS with
Ca2+ and Mg2+. Then cells were processed for staining with the
FITC anti-BrdU or -Ki67, PerCP anti-B220 and biotinylated anti-
IgM, followed by SA-APC staining.
Immunofluorescence Microscopy
and Immunohistochemical Analysis
Spleens from immunized mice were harvested, embedded in Fro-
zen Tissue Media (Fisher Scientific), and snap frozen in liquid nitro-
gen. Four micrometer-thick frozen sections were fixed in acetone
for 15 min and dried in air for 30 min. The sections were blocked
with 5% horse serum for 30 min at room temperature and then
were stained for 30 minutes at room temperature with cocktails of
antibodies and PNA. The following conjugations with Alexa fluor
dyes (Molecule Probes) were performed according to the manufac-
turer’s instructions: PNA (Vector Laboratory) to Alexa 488; anti-
mouse CD35 (8C12, BD Bioscience) to Alexa 350; anti-IgMa (RS3.1)
and anti-Ki67 (B56, BD Bioscience) to Alexa 555; anti-CD4 (GK1.4,
ATCC), anti-IgMa (RS3.1), and anti-IgD (11-26) to Alexa 647. Biotin-
ylated anti-IgD was from Southern Biotechnology Associates, and
biotinylated anti-BrdU and IgG1 from BD Biosciences. Biotinylated
antibodies were revealed by strepavidin-Alexa 555 (Molecular
Probes). Sections were mounted in Fluormount G (Southern Bio-
technology Associates) and viewed with a Leica/Leitz DMRB
microscope. False colors are used to increase contrast. Except as
stated otherwise, green represents signals for Alexa 488 staining,
blue for Alexa 350, red for Alexa 555, and magenta for Alexa 647.
For BrdU staining, tissue sections were denatured in 0.1 N HCL for
20 min at room temperature, followed by PNA and anti-BrdU stain-
ing. For analysis of mitotic figures, spleens were fixed in neutral
buffered formalin and embedded in paraffinn, and 3 m sections
were stained by hematoxylin and eosin (H&E), by TUNEL, and for
anti-Ki67. Histology experiments were repeated on at least three
mice, and representative staining patterns are shown.
Sequence Analysis of V4/5 Family-J5 Genes
CD19+/+ and CD19 Y482F/Y513F Tg mice were immunized with
phOx-CSA precipitated with alum, and PNA+B220+ cells were puri-
fied by cell sorting on day 14 after immunization. Lysates from
these cells (equal to 20,000 cells) were amplified by PCR with the
use of Taq Polymerase (Fisher Scientific) and the forward Vκ4/5
family primer 5#-CAAATTGTTCTCACCCAGTCTCCA-3# and reverse
Jκ5 primer 5#-CGTTTCAGCTCCAGCTTGGTCCCAG-3# for 35 cy-
cles, annealing at 60°C. PCR products were subcloned into the TA
vector (Invitrogen), and individual clones were selected for se-
quencing. The presumptive Vκ4/5 Jκ5 genes were determined by
using the DnaPlot program (www.dnaplot.de), and mismatches
were marked as somatic mutations.
Statistical Analysis
Student’s t test was used to analyze the statistical differences be-
tween CD19 normal and CD19 Y482F/Y513F Tg groups, and p val-
ues less than 0.05 were considered statistically significant and indi-
cated in the appropriate graphs.
Supplemental Data
Supplemental Data are available with this article online at http://
www.immunity.com/cgi/content/full/22/6/749/DC1/.
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